Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct 23;11:55-67.
doi: 10.2147/SCCAA.S155410. eCollection 2018.

Stem Cell Therapy in Autism: Recent Insights

Affiliations
Free PMC article
Review

Stem Cell Therapy in Autism: Recent Insights

Dario Siniscalco et al. Stem Cells Cloning. .
Free PMC article

Abstract

Autism spectrum disorders (ASDs) are characterized by core domains: persistent deficits in social communication and interaction; restricted, repetitive patterns of behavior, interests, or activities. ASDs comprise heterogeneous and complex neurodevelopmental pathologies with well-defined inflammatory conditions and immune system dysfunction. Due to neurobiologic changes underlying ASD development, cell-based therapies have been proposed and applied to ASDs. Indeed, stem cells show specific immunologic properties, which make them promising candidates in ASD treatment. This comprehensive up-to-date review focuses on ASD cellular/molecular abnormalities, potentially useful stem cell types, animal models, and current clinical trials on the use of stem cells in treating autism. Limitations are also discussed.

Keywords: autism spectrum disorder; cell therapy; immune dysfunction; stem cell.

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Similar articles

See all similar articles

Cited by 4 articles

References

    1. Courchesne E, Pramparo T, Gazestani VH, Lombardo MV, Pierce K, Lewis NE. The ASD living biology: from cell proliferation to clinical phenotype. Mol Psychiatry. 2018June:22. Epub. - PMC - PubMed
    1. Geschwind DH. Advances in autism. Annu Rev Med. 2009;60:367–380. - PMC - PubMed
    1. Chaste P, Leboyer M. Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin Neurosci. 2012;14(3):281–292. - PMC - PubMed
    1. Mottron L, Belleville S, Rouleau GA, Collignon O. Linking neocortical, cognitive, and genetic variability in autism with alterations of brain plasticity: the Trigger-Threshold-Target model. Neurosci Biobehav Rev. 2014;47:735–752. - PubMed
    1. Iovene MR, Bombace F, Maresca R, et al. Intestinal dysbiosis and yeast isolation in stool of subjects with autism spectrum disorders. Mycopathologia. 2017;182(3–4):349–363. - PubMed

LinkOut - more resources

Feedback